SCHEMBL16264292

SCHEMBL16264292

CCC1=CC=CCN1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3345941 0.81
SCHEMBL8201407 0.81
SCHEMBL7373104 0.81
SCHEMBL4423508 0.79
SCHEMBL10703920 0.79
SCHEMBL17963058 0.78
SCHEMBL3925231 0.78 CYP2C9 (0.31)
SCHEMBL4428325 0.76
SCHEMBL10077299 0.73
SCHEMBL5709793 0.73 HTT (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020228596-A1 SUBSTITUTED FLUORINE-CONTAINING IMIDAZOLE SALT COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF 厦门华绰生物医药科技有限公司 2020-11-19 WO disclosed
EP-3608312-A1 SUBSTITUTED IMIDAZOLE SALT COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND APPLICATIONS THEREOF Xiamen Vivohealths Technology Co., Ltd. (CN) 2020-02-12 EP disclosed
US-20140350244-A1 FUSED PYRIDINE, PYRIMIDINE AND TRIAZINE COMPOUNDS AS CELL CYCLE INHIBITORS AMGEN INC (US) 2014-11-27 US disclosed